Aim: Cardiovascular disease is becoming increasingly more problematic in Mongolia. The cardioankle vascular index (CAVI) and circulating C-reactive protein (CRP) are new atherosclerosis-related parameters, but no comparative studies of atherosclerotic parameters including CAVI and CRP are available between Mongolian and Japanese populations, such as disease populations of hypertension (HT) and diabetes mellitus (DM). Our study objective was to examine atherosclerotic profiles in HT and DM patients in both countries. Methods: From a hospital-based population, 156 Mongolian outpatients with HT and DM (men: 46%, mean age: 57.1 years) and 156 age-and sex-matched Japanese outpatients with HT and DM (men: 46%, age: 57.7) were recruited. Body mass index (BMI), heart rate (HR), blood pressure (BP), pulse pressure (PP), ankle-brachial index (ABI), ultrasonographic carotid intima-media thickness (IMT), blood total cholesterol (T-Cho), glucose, insulin and homeostasis model assessment of insulin resistance (HOMA-IR) were measured, in addition to CAVI and CRP. Results: The levels of BMI, HR, BP, PP, insulin and IMT were significantly higher and T-Cho and glucose were significantly lower in the Mongolian patients in comparison to the Japanese patients. Particularly, the levels of CAVI (mean SD) (8. 1 1.1 vs. 8.8 1.2) and CRP (median [interquartile range]) (0.05 [0.03 − 0.12] vs. 0.19 [0.09 − 0.42] mg/dL) were significantly higher in Mongolian than Japanese patients. These significant differences remained unchanged, even after taking into account multiple variables, including BP and HOMA-IR. In addition, except for CAVI in the subgroup of DM, generally similar trends regarding atherosclerotic parameters were seen in the subgroup by sex and disease (HT, DM and HT plus DM). Conclusion: These findings suggest that Mongolian patients with HT and DM may be at higher risk for cardiovascular disease than Japanese patients.
Introduction
Atherosclerosis is the leading pathology of cardiovascular disease (CVD) and is currently a major worldwide cause of mortality 1) . The World Health Organization (WHO) statistical data in 2005 reported Mongolian people to have a 17-year shorter life expectancy than Japanese people 2) . CVD has been increasing and has become a more important public health problem than cancer in Mongolia 3) . From the data in 2006 among Mongolians (aged 15 − 64 years), the prevalence of hypertension (HT) was 28.1% and diabetes mellitus (DM) was 8.2%, respectively, thus suggesting that both are common diseases (the same has been said in Japan) 4) . Young and healthy Mongolian people could have a higher risk for CVD than Japanese people of a similar generation 5) . International comparative studies may give some insights to determine atherosclerotic traits among Mongolian and Japanese subjects, since the Japanese have a clearly higher average lifespan.
The cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI) are both known to be indexes associated with atherosclerotic risk factors 6) . In particular, CAVI is a new index of arterial stiffness, and is more independent of systolic and diastolic blood pressure (SBP and DBP) than the measurement of pulse wave velocity (PWV) 6) . ABI is also useful for the diagnosis of low extremity peripheral arterial stenotic disease 7) ; therefore, CAVI and ABI are considered to be associated with CVD occurrence 6, 8) .
Atherosclerotic risk factors, such as age, male sex, smoking, lack of exercise, obesity, dyslipidemia, DM and HT, are usually considered in the pathophysiology of CVD 9, 10) . In addition, inflammatory processes have recently received a great deal of attention in atherogenesis, and C-reactive protein (CRP) is one of the representative markers 11) . However, there are few comparative studies on atherosclerosis between Mongolian and Japanese populations 5, 12) , and there are no such studies examining CAVI and CRP in particular in patients with atherosclerosis-related diseases. Therefore, the objective of the present study was to compare the atherosclerotic traits, including CAVI and CRP, between Mongolian and Japanese patients with HT and DM.
Subjects and Methods
The recruitment of patients for this study was carried out between 2006 and 2008 at the Hospital Number 2 and the State Mental Hospital of Mongolia (Ulaanbaatar city, Mongolia) for Mongolians and at the Jichi Medical University Hospital (Tochigi Prefecture, Japan) for Japanese, respectively. This study was approved by the Ethics Committee of Jichi Medical University and the Mongolian Ministry of Health, and each patient gave their informed consent. Initially, adult outpatients (≥ 20 years of age) with HT and DM, without a medical history of CVD and without serum levels of ≥ 220 mg/dL in total cholesterol (T-Cho) and ≥ 150 mg/dL in triglyceride (TG) 13) , were consecutively recruited from a random invitation to participate in the present study. HT was defined as ≥ 140 mmHg systolic blood pressure (SBP) and/or ≥ 90 mmHg diastolic blood pressure (DBP) or the use of drugs against HT 14) . DM was defined as ≥ 126 mg/dL fasting plasma glucose or the use of drugs against DM 15) . Whether drugs for HT and/or DM were prescribed was confirmed by self-reports (the precise names of the drugs themselves were not required). During this initial recruitment, 199 Mongolian patients and 166 Japanese patients were enrolled, respectively. Of the 199 Mongolian patients, 21 patients, who were unsure of the indication for the drugs they used for HT and DM, were excluded. Next, considering the imbalanced distribution of age to compare the Mongolian and Japanese patient groups (the age range of Mongolian patients was relatively wide), from the initial Mongolian patients (n 178) and Japanese (n 166), age-and sex-matched data (1:1 ratio with 1 year of age in respective Mongolian and Japanese patient groups) were selected in a further random manner. The age range of patients in this selection was 30 to 69 years. Thereafter, the final study cohort included 156 Mongolian patients with HT and DM (men: 71, women: 85; mean age: 57.1 years) and 156 Japanese patients with HT and DM (men: 71, women: 85; age: 57.7 years). The percentages of HT alone, DM alone and HT plus DM were 46.8% (n 73), 30.8% (n 48) and 22.4% (n 35) among Mongolian patients, and 48.1% (n 75), 28.2% (n 44) and 23.7% (n 37) among Japanese patients, respectively.
The patients self-reported their smoking habits, which were defined as current or former/never smokers. Body mass index (BMI) was calculated as the weight divided by the square of the body height while wearing light clothes. Blood samples were collected from the antecubital vein after a 12-hr overnight fast and serum/plasma samples were stored at 80 . Blood measurements were performed at one laboratory facility in Japan. The serum T-Cho and plasma glucose were measured enzymatically and plasma insulin was measured by a sandwich enzyme immunoassay (TOSOH Co. Ltd., Tokyo, Japan). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated based on the plasma insulin and glucose levels, as described previously 16) . Serum CRP was measured using a latex agglutination immune assay (EIKEN Chemical, Co. Ltd., Tokyo, Japan). CAVI was determined by oscillometry using the VaSera VS-1000 vascular screening system (Fukuda Denshi Co. Ltd., Tokyo, Japan). CAVI values are based on the stiffness parameter calculated using the following formula: CAVI a {(2 / P) ln(Ps-Pd) PWV 2 } b; that is, Ps: SBP, Pd: DBP, : blood density, P: (Ps-Pd), PWV: pulse wave velocity, a and b: constants 6) . The values of SBP, DBP, heart rate (HR) and pulse pressure (PP: calculated as SBP minus DBP) were measured in a simultaneous setting. Next, after relaxing for 5 minutes in the supine position, the intima-media thickness (IMT) of the bilateral common carotid arteries of patients was measured by ultrasonography (EH54-9DR system; DIASUS, Scotland, UK). IMT levels were determined by the average values at points 1, 2 and 3 cm below the carotid bifurcation on each side of the artery.
Statistical Analyses
Data are presented as the mean standard deviation. Parameters with non-parametric distributions are shown as the median and interquartile range. In all analyses, parameters with non-parametric distributions were used after log-transformation. Comparisons between groups were examined using the unpaired t -test (for continuous variables) and the 2 -test (for categorical variables). Since the smoking percentage could differe between Mongolian and Japanese patients, smoking was usually considered to be a confounding factor. Comparisons with adjustments for smoking and other factors were analyzed using the general linear model, entering the adjusted variables as co-variables. All statistical analysies were performed with the Statistical Package for Social Science (SPSS) version 16.0 for Windows (SPSS Inc., Chicago, USA). A p-value 0.05 was considered significant.
Results
The clinical characteristics of the measured parameters in all patients are listed in Table 1 . The levels of BMI, HR, SBP, DBP, PP, insulin, CRP, IMT and CAVI were significantly higher and the levels of T-Cho and glucose were significantly lower in Mongolian patients than Japanese patients. There was no significant difference between the percentage of drugtreated Mongolian and Japanese patients. Table 2 shows the differences in atherosclerotic parameters by sex between Japanese and Mongolian patients. Except for the ABI and smoking status in women, no differences by sex were observed: the levels of BMI, SBP, DBP, PP, insulin, CRP, IMT and CAVI were significantly higher and T-Cho and insulin were significantly lower in Mongolian patients than in Japanese patients in both sexes.
Moreover, concerning the higher levels of CRP and CAVI in Mongolian patients than Japanese patients for both sexes (as shown in For CRP, p-values for differences in levels between Japanese and Mongolian patients were 0.01 (significant) in all models, regardless of sex. Also, for CAVI, p-values for differences between patients were 0.01 (0.03 in Model only) (significant) in all models, regardless of sex. Therefore, even with these adjustments, the results regarding the differences in CRP and CAVI levels remained unchanged. Table 3 shows the differences in atherosclerotic parameters between Japanese and Mongolian patients by HT and DM. In the population of HT alone, the levels of BMI, SBP, DBP, PP, insulin, CRP, IMT and CAVI were significantly higher, and the levels of glucose were significantly lower in Mongolian patients than Japanese patients. In the population of DM alone, the levels of BMI, HR, DBP, insulin and CRP were significantly higher, and glucose was significantly lower in Mongolian patients than Japanese patients. The levels of SBP, PP and CAVI in Mongolian DM patients were relatively similar to those of Japanese DM patients. In the population of HT plus DM, the levels of SBP, DBP, PP, CRP, IMT and CAVI were significantly higher in Mongolian patients than Japanese patients.
Following the results of Table 3 , Table 4 shows the data obtained from a subanalysis of patients matched according to the SBP and DBP levels (1:1 ratio with 1 mm Hg in the respective Mongolian and Japanese patients) in the population of HT alone. Even in the current subanalysis, the differences in atherosclerotic parameters including CRP, IMT and CAVI between Mongolian and Japanese patients similarly remained.
Discussion
The present study is the first attempt to compare atherosclerotic parameters, including CAVI and CRP in particular, between populations of HT and DM patients in Mongolia and Japan. Notably, the overall levels of atherosclerotic parameters had higher tendencies, despite lower levels of T-Cho and glucose, in Mongolian patients than Japanese patients. Namely, the levels of BMI, HR, SBP, DBP, insulin, CRP, IMT and CAVI were significantly higher in Mongolian patients. While higher levels of several atherosclerotic parameters have been reported in Mongolian young and healthy people in comparison to similar Japanese people 5) , the present study findings may be valuable, if consistent with the study on young people and if the higher mortality rates of CVD in Mongolian people are relevant to the higher levels of atherosclerotic parameters in comparison to Japanese people. CAVI is a newly developed index of arterial stiffness and its clinical significance in CVD has recently been established 6, 17) . Also, CRP has recently been identified to be a clinical useful atherosclerosis-related marker with accumulated data, for instance, showing up-regulated expression of endothelial adhesion molecules and inhibited expression of nitric oxide synthase in endothelial cells 18, 19) . Atherosclerotic profiles, including these new two markers, between Mongolian and Japanese patients were relatively similar in HT alone and HT plus DM. In DM, the obvious difference in CRP levels between Mongolian and Japanese patients was similar to that in HT and HT plus DM, while no marked difference in CAVI was observed. Although the reasons for this result in regard to the association with CAVI in DM were unclear, the nonsignificant but slightly younger age in Mongolians in comparison to Japanese DM patients might have partly affected the result. Regardless, it is important to dis-close higher levels of atherosclerotic parameters such as CRP in patients with HT, DM and HT plus DM, and/or as CAVI in patients with HT and HT plus DM. Insulin resistance is generally regarded as one of the underlying mechanisms of these disorders 20) . Our Mongolian patients with both HT and DM presented higher levels of BMI and insulin, a suggestive parameter of greater insulin resistance, in comparison to the Japanese patients. Furthermore, an earlier work has reported greater levels of insulin resistance in Mongolian workers than Japanese workers 21) . However, interestingly, our study showed that significant differences in CRP and CAVI between Japanese and Mongolian patients were maintained, even after adjusting for factors related to insulin resistance (e.g., BMI, HOMA-IR) and/or other factors, such as blood pressure levels. One possible explanation for this may be the existence of differences in environmental factors. The enhanced effect of high altitude on not only blood pressure 22) but CAVI 5, 23) in Mongolia has been reported. The lowered effect of high altitude on plasma glucose has also been reported 24) , and in fact our studied Mongolian DM patients had lower glucose levels. From the biological viewpoint in association with altitude, an increase in oxidative stress (via reactive oxygen metabolism) in Mongolian people compared with Japanese people 25, 26) has been reported, and this may cause differences in atherosclerotic parameters 27) . Additionally, genetic factors could have played roles in the present results. Whereas the genetic background of Mongolian and Japanese people is generally thought to be similar, different frequencies of some gene polymorphisms have been suggested [28] [29] [30] . These factors are thought to merit further investigation to elucidate such differences between Mongolian and Japanese patients, while more unmeasured factors might remain hidden.
The present study had strength in that all measurements were performed using the same methodology and at the same central facility, which is necessary in an international comparative study; however, there were a few potential limitations. The cross-sectional design did not address the cause-and-effect. In the population of HT and DM, information on the duration and degree of disease and the precise medication was not fully examined. Differences in medical circumstances can also induce differences in atherosclerotic parameters between the two populations. Different medication strategies (e.g., greater usage of angiotensin-converting enzyme inhibitors in Mongolian HT patients and angiotensin receptor blockers in Japanese HT patients) might result in some differences. Actually, blood hemoglobin A1c, a long-term glyce- mic parameter, is not usually measured in Mongolia, in contrast to Japan, and this might effect the disease management between countries (although Mongolian and Japanese patients do not seem to have a large different background because of the diagnostic criteria for DM by WHO, as mentioned above). The absence of detailed information is thought to be a great limitation; therefore, more sophisticated research is called for in any future surveys.
In summary, the current study found, on the whole, more atherosclerotic traits, including CAVI and CRP, in addition to BMI, HR, SBP, DBP, PP and insulin, in Mongolian patients with HT and DM than Japanese patients. This suggests that Mongolian patients may be at higher risk for CVD than Japanese patients. Further studies are needed to clarify the mechanisms of higher levels of atherosclerotic parameters in Mongolian patients.
